In human tumors, ELISA measurements of ProT alpha (detected through its thymosin alpha1 fragment) were comparable with, but twofold greater than, earlier RIA values.
In plain wordsIn lab tests on human tumour samples, a new ELISA gave results similar to an older assay, but twice as high.
- Peptide
- Thymosin alpha-1
- Outcome
- Not applicableProT alpha concentration by ELISA versus RIA
- Study
humann: not reported in source
human tumor tissue (skin, esophagus, colorectal, breast)- Comparator
- Earlier RIA values
- Outcome group
- Analytical methods and detection · Cancer
Source sentences
ProT alpha concentrations in various human tumors (skin, esophagus, colorectal, and breast) as assessed by ELISA were comparable with, although twofold greater than, the values previously estimated by RIA.
1 context sentence(design, population, supporting numbers)
In that study ProT alpha concentrations were measured by a RIA; here we present an alternative nonisotopic assay that could be used in a standard clinical laboratory.
In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.